As of Thursday close, ArcBest Corporation’s (NASDAQ:ARCB) stock was up $0.94, moving up 0.95 percent to $99.40. The average number of shares traded per day over the past five days has been 944,760 shares. 2 times new highs have been achieved over the past 5 days, with a -$3.80 fall in that time frame. In the last twenty days, the average volume was 582,270, while in the previous 50 days, it was 517,282.
Since last month, ARCB stock retreated -6.08%. Shares of the company fell to $96.48 on 09/12/23, the lowest level in the past month. A 52-week high of $122.86 was reached on 07/27/23 after having rallying from a 52-week low of $68.00. Since the beginning of this year, ARCB’s stock price has risen by 41.92% or $29.36, and marked a new high 19 times. However, the stock has declined by -19.09% since its 52-week high.
ARCB stock investors should be aware that ArcBest Corporation (ARCB) stock had its last reported insider trading activity 8 days ago on Sep 14. Beasley John Matthew, the CFO and Treasurer(1) of the company, purchased of 1,000 shares for $104.98 on Sep 14. It resulted in a $104,980 investment by the insider. MCELLIGOTT KATHLEEN D sold 5,000 shares at an average price of $110.24 on Sep 01. The insider now owns 18,900 shares following the transaction. On Aug 23, Chief Strategy Officer Anderson Dennis L II sold 1,962 shares at $104.74 apiece. The transaction was valued at $205,507.
Valuation Metrics
Right now, ArcBest Corporation (ARCB) has a P/E ratio of about 13.53. The stock’s beta is 1.59. Besides these, the trailing price-to-sales (P/S) ratio of 0.50, the price-to-book (PB) ratio of 1.97, and the price-to-cash flow ratio of 12.56 may also be considered.
The latest dividend of $0.12 per share was paid out, remained unchanged from last year’s $0.12. On Thursday April 28 2022, a $0.04 dividend increase was announced.
Financial Health
In the three months ended June 29, ArcBest Corporation’s quick ratio stood at 1.30, while its current ratio was 1.30, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.14, and the total debt-to-equity ratio was 0.19. On the profitability front, the trailing twelve-month gross margin is 79.70% percent. In the year ended June 29, EBITDA margin amounted to 10.23%, whereas operating margins totaled 4.80%. Based on annual data, ARCB earned $399.27 million in gross profit and brought in $5.32 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 21.50%. Return on equity (ROE) for the past 12 months was 20.30%.
In ArcBest Corporation’s quarter-end financial report for June 29, it reported total debt of $168.11 million. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. ARCB’s revenue fell -26.23% to $1.11 billion during the quarter, while net income inched up to $1.1 billion. While analysts expected ArcBest Corporation to report $2.05 quarterly earnings, the actual figure was $1.54 per share, beating the consensus estimate by -24.90%. During the quarter, the company generated $77.93 million in EBITDA. The liabilities of ArcBest Corporation were 1.2 billion at the end of its most recent quarter ended June 29, and its total debt was $438.18 million. The value of shareholders’ equity is $24.02 million.
Technical Picture
This quick technical analysis looks at ArcBest Corporation’s (ARCB) price momentum. With a historical volatility rate of 27.37%, the RSI 9-day stood at 41.59% on 21 September.
With respect to its five-day moving average, the current ArcBest Corporation price is down by -3.68% percent or -$3.80. At present, ARCB shares trade -5.77% below its 20-day simple moving average and +5.30% percent above its 100-day simple moving average. However, the stock is currently trading approximately +2.95% above its SMA50 and +22.76% above its SMA200.
Stochastic coefficient K was 17.10% and Stochastic coefficient D was 24.86%, while ATR was 3.93. Given the Stochastic reading of 18.35% for the 14-day period, the RSI (14) reading has been calculated as 42.93%. As of today, the MACD Oscillator reading stands at -1.27, while the 14-day reading stands at -2.43.
Analyst Ratings
UBS launched its rating on ArcBest Corporation (NASDAQ: ARCB) to a Neutral in a note to investors on September 18, 2023. ArcBest Corporation (ARCB) has been rated Overweight by analysts. According to 0 brokerage firms, ARCB is a sell, and 2 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 0 analysts rate ArcBest Corporation stock as buy, with 8 recommending it as overweight.
With a median target price of $135.00, the current consensus forecast for the stock is $110.00 – $150.00. Based on these forecasts, analysts predict ArcBest Corporation (ARCB) will achieve an average price target of $132.45.
